A cGMP inspection was conducted by the USFDA at the manufacturing facility of the Marksans Pharma's wholly owned subsidiary ...

On conclusion of the inspection, the Subsidiary has received One (1) inspectional observation in Form 483. There is no data integrity observation. The Subsidiary will work closely with the USFDA and ...

Mumbai: Marksans Pharma has announced that the US Food and Drug Administration (USFDA) has concluded an inspection with one ...

Pune: In a recent BSE filing, Emcure Pharma has informed that the Company has received the Establishment Inspection Report ...

Increases its competitiveness in the field of drug containment solutions and builds the largest ampoule manufacturing ...

New system aims to cut delays, ensure compliance, and elevate global trust in Pakistan's pharmaceutical sector ...

Indian drugmakers Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus are recalling several medicines from ...

A US-based subsidiary of Sun Pharma is recalling around 13,700 bottles of Gabapentin capsules, a medication used to treat and prevent seizures in people with epilepsy.

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...